Takayuki Ikezoe
Fukushima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 187 publications
Coagulopathy in acute promyelocytic leukaemia: Can we better predict and prevent catastrophic bleeding?
Journal: Thrombosis research
Published: March 17, 2026
Serum Syndecan-1: a potent prognostic biomarker for transplant outcomes.
Journal: Frontiers in medicine
Published: March 11, 2026
Cold Agglutinin Disease-Like Genetic Signatures in Lymphoplasmacytic Lymphoma-Like Cases Challenge the WHO Fifth Edition Classification.
Journal: EJHaem
Published: March 10, 2026
Diagnostic delay and clinical outcomes of paroxysmal nocturnal hemoglobinuria: a retrospective cohort study using Japanese claims data.
Journal: International journal of hematology
Published: March 04, 2026
Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.
Journal: British journal of haematology
Published: February 21, 2026
Thrombotic Microangiopathy-Like Phenotype in Patients With Infection-Associated Disseminated Intravascular Coagulation Treated With Thrombomodulin Alfa.
Journal: European journal of haematology
Published: February 19, 2026
Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.
Journal: Blood cancer journal
Published: February 14, 2026
SCRUM-Japan MONSTAR3 hematology cohort: a nationwide multi-omics integrated platform for next-generation precision medicine in hematologic malignancies.
Journal: International journal of clinical oncology
Published: February 12, 2026
Adults With Acid Sphingomyelinase Deficiency Have Sustained Improvements in Clinical Outcomes With up to 5 Years of Olipudase Alfa Enzyme Replacement Therapy: ASCEND Trial Final Results.
Journal: Journal of inherited metabolic disease
Published: January 08, 2026
Thrombotic Events in Patients With Paroxysmal Nocturnal Haemoglobinuria Using Eculizumab: A Post-Marketing Surveillance Sub-Analysis.
Journal: EJHaem
Published: November 17, 2025
Dismal Outcome of EBV-Positive Nodal T/NK-Cell Lymphoma: A Multicenter Retrospective Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 14, 2025
A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysis.
Journal: Therapeutic advances in hematology
Published: September 04, 2025
Last Updated: 09/26/2026